Neoadjuvant (presurgical) therapy for renal cell carcinoma: A new treatment paradigm for locally advanced and metastatic disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant (presurgical) therapy for renal cell carcinoma: A new treatment paradigm for locally advanced and metastatic disease

Published:2009-04-28 Issue:S10 Volume:115 Page:2355-2360
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Wood Christopher G.¹,Margulis Vitaly¹

Affiliation:

1. Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Funder

Genentech, Novartis Pharmaceuticals, Pfizer, Inc., and Wyeth Pharmaceuticals

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.24240

Reference15 articles.

1. Surgical Management of Renal Cell Carcinoma

2. The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma

3. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

4. Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

5. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-03

2. Renal Tumors;Oncologic Imaging : a Multidisciplinary Approach;2023

3. Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?;Archivio Italiano di Urologia e Andrologia;2022-12-28

4. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis;2020-12-23

5. C-Reactive Protein Levels and Survival Following Cytoreductive Nephrectomy in 118 Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Study;Medical Science Monitor;2019-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3